Lin Qin, Zheng Longxiang, Chen Xiaoqiang, Wang Desheng
Department of Otolaryngology, Fujian Medical University Union Hospital, No. 29, Xinquan Road, Fujian, Fuzhou, 350001, Fujian, China.
Sci Rep. 2025 Apr 15;15(1):13033. doi: 10.1038/s41598-025-89223-6.
To determine an optimal cut-off value for distinguishing early and late recurrence in patients with laryngeal cancer after initial surgery and to evaluate the risk factors for early recurrence. This retrospective study included 328 patients with laryngeal cancer who underwent initial resection in our hospital from January 2014 to April 2018. A minimum P-value approach was used to determine the optimal cut-off value to divide patients into early and late recurrence groups. The clinicopathological characteristics were compared between the two groups. The risk factors for early recurrence were evaluated using logistic regression analysis. The optimal cut-off value to identify between early recurrence (n = 51, 50.5%) and late recurrence (n = 50, 49.5%) was 17 months (p < 1e). The overall survival of the late recurrence group (48.36 ± 16.02 months) was longer than the early recurrence group (32.61 ± 19.65 months) significantly (p < 0.001). Lymphovascular invasion (p = 0.038), patients without adjuvant radiotherapy (p = 0.043), advanced tumor, node, metastasis (TNM) stage (p = 0.035), and positive surgical margins (p = 0.045) were independent risk factors for early recurrence. The best cut-off value to identify early recurrence after initial surgery for laryngeal cancer was 17 months. Intensive follow-up and adjuvant radiotherapy may be beneficial for patients with risk factors for early recurrence.
确定区分喉癌患者初次手术后早期和晚期复发的最佳临界值,并评估早期复发的危险因素。这项回顾性研究纳入了2014年1月至2018年4月在我院接受初次切除的328例喉癌患者。采用最小P值法确定将患者分为早期和晚期复发组的最佳临界值。比较两组的临床病理特征。采用逻辑回归分析评估早期复发的危险因素。区分早期复发(n = 51,50.5%)和晚期复发(n = 50,49.5%)的最佳临界值为17个月(p < 1e)。晚期复发组的总生存期(48.36±16.02个月)明显长于早期复发组(32.61±19.65个月)(p < 0.001)。淋巴管浸润(p = 0.038)、未接受辅助放疗的患者(p = 0.043)、晚期肿瘤、淋巴结、转移(TNM)分期(p = 0.035)和手术切缘阳性(p = 0.045)是早期复发的独立危险因素。识别喉癌初次手术后早期复发的最佳临界值为17个月。对有早期复发危险因素的患者进行密切随访和辅助放疗可能有益。